Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
27
07
2022
received:
01
03
2022
accepted:
18
08
2022
pubmed:
21
8
2022
medline:
7
12
2022
entrez:
20
8
2022
Statut:
ppublish
Résumé
Bazex-Dupré-Christol syndrome (BDCS; MIM301845) is a rare X-linked dominant genodermatosis characterized by follicular atrophoderma, congenital hypotrichosis and multiple basal cell carcinomas (BCCs). Previous studies have linked BDCS to an 11·4-Mb interval on chromosome Xq25-q27.1. However, the genetic mechanism of BDCS remains an open question. To investigate the genetic aetiology and molecular mechanisms underlying BDCS. We ascertained multiple individuals from eight unrelated families affected with BDCS (F1-F8). Whole-exome (F1 and F2) and genome sequencing (F3) were performed to identify putative disease-causing variants within the linkage region. Array comparative genomic hybridization and quantitative polymerase chain reaction (PCR) were used to explore copy number variations, followed by long-range gap PCR and Sanger sequencing to amplify the duplication junctions and to define the head-tail junctions. Hi-C was performed on dermal fibroblasts from two affected individuals with BDCS and one control. Public datasets and tools were used to identify regulatory elements and transcription factor binding sites within the minimal duplicated region. Immunofluorescence was performed in hair follicles, BCCs and trichoepitheliomas from patients with BDCS and sporadic BCCs. The ACTRT1 variant c.547dup (p.Met183Asnfs*17), previously proposed to cause BDCS, was evaluated with t allele frequency calculator. In eight families with BDCS, we identified overlapping 18-135-kb duplications (six inherited and two de novo) at Xq26.1, flanked by ARHGAP36 and IGSF1. Hi-C showed that the duplications did not affect the topologically associated domain, but may alter the interactions between flanking genes and putative enhancers located in the minimal duplicated region. We detected ARHGAP36 expression near the control hair follicular stem cell compartment, and found increased ARHGAP36 levels in hair follicles in telogen, in BCCs and in trichoepitheliomas from patients with BDCS. ARHGAP36 was also detected in sporadic BCCs from individuals without BDCS. Our modelling showed the predicted maximum tolerated minor allele frequency of ACTRT1 variants in control populations to be orders of magnitude higher than expected for a high-penetrant ultra-rare disorder, suggesting loss of function of ACTRT1 variants to be an unlikely cause for BDCS. Noncoding Xq26.1 duplications cause BDCS. The BDCS duplications most likely lead to dysregulation of ARHGAP36. ARHGAP36 is a potential therapeutic target for both inherited and sporadic BCCs. What is already known about this topic? Bazex-Dupré-Christol syndrome (BDCS) is a rare X-linked basal cell carcinoma susceptibility syndrome linked to an 11·4-Mb interval on chromosome Xq25-q27.1. Loss-of-function variants in ACTRT1 and its regulatory elements were suggested to cause BDCS. What does this study add? BDCS is caused by small tandem noncoding intergenic duplications at chromosome Xq26.1. The Xq26.1 BDCS duplications likely dysregulate ARHGAP36, the flanking centromeric gene. ACTRT1 loss-of-function variants are unlikely to cause BDCS. What is the translational message? This study provides the basis for accurate genetic testing for BDCS, which will aid precise diagnosis and appropriate surveillance and clinical management. ARHGAP36 may be a novel therapeutic target for all forms of sporadic basal cell carcinomas.
Sections du résumé
BACKGROUND
Bazex-Dupré-Christol syndrome (BDCS; MIM301845) is a rare X-linked dominant genodermatosis characterized by follicular atrophoderma, congenital hypotrichosis and multiple basal cell carcinomas (BCCs). Previous studies have linked BDCS to an 11·4-Mb interval on chromosome Xq25-q27.1. However, the genetic mechanism of BDCS remains an open question.
OBJECTIVES
To investigate the genetic aetiology and molecular mechanisms underlying BDCS.
METHODS
We ascertained multiple individuals from eight unrelated families affected with BDCS (F1-F8). Whole-exome (F1 and F2) and genome sequencing (F3) were performed to identify putative disease-causing variants within the linkage region. Array comparative genomic hybridization and quantitative polymerase chain reaction (PCR) were used to explore copy number variations, followed by long-range gap PCR and Sanger sequencing to amplify the duplication junctions and to define the head-tail junctions. Hi-C was performed on dermal fibroblasts from two affected individuals with BDCS and one control. Public datasets and tools were used to identify regulatory elements and transcription factor binding sites within the minimal duplicated region. Immunofluorescence was performed in hair follicles, BCCs and trichoepitheliomas from patients with BDCS and sporadic BCCs. The ACTRT1 variant c.547dup (p.Met183Asnfs*17), previously proposed to cause BDCS, was evaluated with t allele frequency calculator.
RESULTS
In eight families with BDCS, we identified overlapping 18-135-kb duplications (six inherited and two de novo) at Xq26.1, flanked by ARHGAP36 and IGSF1. Hi-C showed that the duplications did not affect the topologically associated domain, but may alter the interactions between flanking genes and putative enhancers located in the minimal duplicated region. We detected ARHGAP36 expression near the control hair follicular stem cell compartment, and found increased ARHGAP36 levels in hair follicles in telogen, in BCCs and in trichoepitheliomas from patients with BDCS. ARHGAP36 was also detected in sporadic BCCs from individuals without BDCS. Our modelling showed the predicted maximum tolerated minor allele frequency of ACTRT1 variants in control populations to be orders of magnitude higher than expected for a high-penetrant ultra-rare disorder, suggesting loss of function of ACTRT1 variants to be an unlikely cause for BDCS.
CONCLUSIONS
Noncoding Xq26.1 duplications cause BDCS. The BDCS duplications most likely lead to dysregulation of ARHGAP36. ARHGAP36 is a potential therapeutic target for both inherited and sporadic BCCs. What is already known about this topic? Bazex-Dupré-Christol syndrome (BDCS) is a rare X-linked basal cell carcinoma susceptibility syndrome linked to an 11·4-Mb interval on chromosome Xq25-q27.1. Loss-of-function variants in ACTRT1 and its regulatory elements were suggested to cause BDCS. What does this study add? BDCS is caused by small tandem noncoding intergenic duplications at chromosome Xq26.1. The Xq26.1 BDCS duplications likely dysregulate ARHGAP36, the flanking centromeric gene. ACTRT1 loss-of-function variants are unlikely to cause BDCS. What is the translational message? This study provides the basis for accurate genetic testing for BDCS, which will aid precise diagnosis and appropriate surveillance and clinical management. ARHGAP36 may be a novel therapeutic target for all forms of sporadic basal cell carcinomas.
Substances chimiques
ACTRT1 protein, human
0
Microfilament Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
948-961Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 British Association of Dermatologists.
Références
Bazex A, Dupre A, Christol B. [Complex genodermatosis of an indeterminate type associating hypotrichosis, a generalized atrophodermic state and multiple cutaneous degenerations]. Bull Soc Franc Derm Syph 1964; 71:206 (in French).
Plosila M, Kiistala R, Niemi KM. The Bazex syndrome: follicular atrophoderma with multiple basal cell carcinomas, hypotrichosis and hypohidrosis. Clin Exp Dermatol 1981; 6:31-41.
Herges A, Stieler W, Stadler R. [Bazex-Dupre-Christol syndrome. Follicular atrophoderma, multiple basal cell carcinomas and hypotrichosis]. Hautarzt 1993; 44:385-91 (in German).
Vabres P, de Prost Y. Bazex-Dupre-Christol syndrome: a possible diagnosis for basal cell carcinomas, coarse sparse hair, and milia. Am J Med Genet 1993; 45:786.
Goeteyn M, Geerts ML, Kint A et al. The Bazex-Dupre-Christol syndrome. Arch Dermatol 1994; 130:337-42.
Yung A, Newton-Bishop JA. A case of Bazex-Dupre-Christol syndrome associated with multiple genital trichoepitheliomas. Br J Dermatol 2005; 153:682-4.
Barcelos AC, Nico MM. Bazex-Dupre-Christol syndrome in a 1-year-old boy and his mother. Pediatr Dermatol 2008; 25:112-13.
Castori M, Castiglia D, Passarelli F et al. Bazex-Dupre-Christol syndrome: an ectodermal dysplasia with skin appendage neoplasms. Eur J Med Genet 2009; 52:250-5.
Kallam AR, Satyanarayana MA, Aryasomayajula S et al. Basal cell carcinoma developing from trichoepithelioma: review of three cases. J Clin Diagn Res 2016; 10:PD17-19.
Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85:841-51.
Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-71.
Smith MJ, Beetz C, Williams SG et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol 2014; 32:4155-61.
Peris K, Fargnoli MC, Garbe C et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118:10-34.
Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8:743-54.
Peterson SC, Eberl M, Vagnozzi AN et al. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell 2015; 16:400-12.
Youssef KK, Lapouge G, Bouvree K et al. Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation. Nat Cell Biol 2012; 14:1282-94.
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754-60.
McKenna A, Hanna M, Banks E et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20:1297-303.
Drmanac R, Sparks AB, Callow MJ et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010; 327:78-81.
Carnevali P, Baccash J, Halpern AL et al. Computational techniques for human genome resequencing using mated gapped reads. J Comput Biol 2012; 19:279-92.
Banka S, Blom HJ, Walter J et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet 2011; 88:216-25.
Sun M, Ma F, Zeng X et al. Triphalangeal thumb-polysyndactyly syndrome and syndactyly type IV are caused by genomic duplications involving the long range, limb-specific SHH enhancer. J Med Genet 2008; 45:589-95.
Chen S, Zhou Y, Chen Y et al. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018; 34: i884-90.
Servant N, Varoquaux N, Lajoie BR et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol 2015; 16:259.
Durand NC, Robinson JT, Shamim MS et al. Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom. Cell Syst 2016; 3:99-101.
Xu W, Zhong Q, Lin D et al. CoolBox: a flexible toolkit for visual analysis of genomics data. BMC Bioinformatics 2021; 22:489.
Dekker J, Belmont AS, Guttman M et al. The 4D nucleome project. Nature 2017; 549:219-26.
Ernst J, Kellis M. Chromatin-state discovery and genome annotation with ChromHMM. Nat Protoc 2017; 12:2478-92.
Fornes O, Castro-Mondragon JA, Khan A et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 2020; 48:D87-92.
Wan J, Dai H, Zhang X et al. Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas. Genes Dis 2021; 8:181-92.
Atwood SX, Sarin KY, Whitson RJ et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell 2015; 27:342-53.
Sand M, Bromba A, Sand D et al. Dicer sequencing, whole genome methylation profiling, mRNA and smallRNA sequencing analysis in basal cell carcinoma. Cell Physiol Biochem 2019; 53:760-73.
Dobin A, Gingeras TR. Mapping RNA-seq reads with STAR. Curr Protoc Bioinformatics 2015; 51:11.4.1-19.
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014; 30:923-30.
Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26:139-40.
Garcia-Mata R, Wennerberg K, Arthur WT et al. Analysis of activated GAPs and GEFs in cell lysates. Methods Enzymol 2006; 406:425-37.
Whiffin N, Minikel E, Walsh R et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med 2017; 19:1151-8.
GnomAD browser. Insertion (1 base):X-127185638-A-AT (GRCh37). Available at: https://gnomad.broadinstitute.org/variant/X-127185638-A-AT?dataset=gnomad_r2_1 (last accessed 23 August 2022).
Bal E, Park HS, Belaid-Choucair Z et al. Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas. Nat Med 2017; 23:1226-33.
Vabres P, Lacombe D, Rabinowitz LG et al. The gene for Bazex-Dupre-Christol syndrome maps to chromosome Xq. J Invest Dermatol 1995; 105:87-91.
Parren LJ, Abuzahra F, Wagenvoort T et al. Linkage refinement of Bazex-Dupre-Christol syndrome to an 11.4-Mb interval on chromosome Xq25-27.1. Br J Dermatol 2011; 165:201-3.
Kidd A, Carson L, Gregory DW et al. A Scottish family with Bazex-Dupre-Christol syndrome: follicular atrophoderma, congenital hypotrichosis, and basal cell carcinoma. J Med Genet 1996; 33:493-7.
Torrelo A, Sprecher E, Mediero IG et al. What syndrome is this? Bazex-Dupre-Christol syndrome. Pediatr Dermatol 2006; 23:286-90.
MacDonald JR, Ziman R, Yuen RK et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 2014; 42:D986-92.
Firth HV, Richards SM, Bevan AP et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 2009; 84:524-33.
Rao SS, Huntley MH, Durand NC et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 2014; 159:1665-80.
Krietenstein N, Abraham S, Venev SV et al. Ultrastructural details of mammalian chromosome architecture. Mol Cell 2020; 78:554-65.
Xu M, Horrell J, Snitow M et al. WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation. Nat Commun 2017; 8:15397.
Colmont CS, Benketah A, Reed SH et al. CD200-expressing human basal cell carcinoma cells initiate tumor growth. Proc Natl Acad Sci U S A 2013; 110:1434-9.
Sun Y, Bak B, Schoenmakers N et al. Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet 2012; 44:1375-81.
Rack PG, Ni J, Payumo AY et al. Arhgap36-dependent activation of Gli transcription factors. Proc Natl Acad Sci U S A 2014; 111:11061-6.
Beckmann PJ, Larson JD, Larsson AT et al. Sleeping beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors. Cancer Res 2019; 79:905-17.
Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol 2009; 19:R132-42.
Reis-Filho JS, Torio B, Albergaria A et al. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002; 29:517-23.
Reijnders MRF, Ansor NM, Kousi M et al. RAC1 missense mutations in developmental disorders with diverse phenotypes. Am J Hum Genet 2017; 101:466-77.
Castilho RM, Squarize CH, Patel V et al. Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells. Oncogene 2007; 26:5078-85.
Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3.
Franke M, Ibrahim DM, Andrey G et al. Formation of new chromatin domains determines pathogenicity of genomic duplications. Nature 2016; 538:265-9.
Beagan JA, Phillips-Cremins JE. On the existence and functionality of topologically associating domains. Nat Genet 2020; 52:8-16.